TickerFacts.

Bausch & Lomb Corp (BLCO): Shareholders' Equity

Annual figures by period end, from SEC filings.

$6.52B
As of 2025-12-31
$6.44B
As of 2026-06-30
-2.8%
3-year compound annual growth
-8.2%
5-year compound annual growth
$9.99B2020-12-31: $9.99B2021-12-31: $9.40B2022-12-31: $7.10B2023-12-31: $6.92B2024-12-31: $6.54B2025-12-31: $6.52B$6.52B
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$6.52B-0.4%2026-02-18, Balance as of period end
2024-12-31$6.54B-5.4%2026-02-18, Balance as of period end
2023-12-31$6.92B-2.5%2026-02-18, Balance as of period end
2022-12-31$7.10B-24.5%2025-02-19, Balance as of period end
2021-12-31$9.40B-5.9%2024-02-21, Balance as of period end
2020-12-31$9.99Bn/a2023-02-22, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Bausch & Lomb Corp (BLCO)2025-12-31$6.52B-0.4%
Cooper Companies, Inc. (COO)2025-10-31$8.24B+1.9%
National Vision Holdings, Inc. (EYE)2026-01-03$869.53M+6.5%
Warby Parker Inc. (WRBY)2025-12-31$367.73M+8.1%
Staar Surgical Co (STAA)2026-01-02$344.18M-13.4%
RxSight, Inc. (RXST)2025-12-31$275.68M-2.0%
Innovative Eyewear Inc (LUCYW)2025-12-31$9.07M-0.3%

Compare BLCO, COO, EYE, WRBY side by side · Screen every company in Ophthalmic Goods ↗